Curbing spending on prescription drugs

Millions of patients suffering from painful and chronic medical conditions could find it easier to access effective and more affordable treatment options, as federal health officials take steps to grow a nascent prescription drug sector known as biosimilars. For Rhode Island, which spends a greater percentage of its gross state product on health care than…
Free Access WeekRegister to read all articles free until July 29! One week only, get full access to all articles on PBN.com when you create a complimentary account. Register Now Already a Subscriber or Registrant? Login now